RenovoRx
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $266 | $422 | $197 | $43 |
Gross Profit | 213 | 270 | 103 | |
EBITDA | -2,911 | -2,677 | -2,419 | |
EBIT | -2,912 | -2,678 | -2,420 | -2,632 |
Net Income | -2,912 | -2,895 | -2,420 | -2,878 |
Net Change In Cash | 266 | 422 | 197 | 43 |
Free Cash Flow | -2,270 | -2,302 | -3,383 | -2,442 |
Cash | 10,044 | 12,314 | 14,582 | 7,154 |
Basic Shares | 36,646 | 36,576 | 31,395 | 24,034 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $43 | $0 | $0 | $0 |
Gross Profit | 43 | 0 | -6 | -9 |
EBITDA | -10,970 | -11,390 | -9,944 | -5,481 |
EBIT | -10,970 | -11,396 | -9,950 | -5,490 |
Net Income | -8,814 | -10,232 | -9,771 | -6,324 |
Net Change In Cash | 43 | 0 | 0 | 0 |
Free Cash Flow | -9,137 | -10,258 | -8,811 | -5,931 |
Cash | 7,154 | 1,173 | 4,391 | 15,192 |
Basic Shares | 23,605 | 20,581 | 18,103 | 17,867 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.08 |
2025-06-30 | -$0.08 |
2025-03-31 | -$0.11 |
